Exact Mass: 320.05638080000006
Exact Mass Matches: 320.05638080000006
Found 105 metabolites which its exact mass value is equals to given mass value 320.05638080000006,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
trans-3,3',4',5,5',7-Hexahydroxyflavanone
(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration. It has a role as a metabolite, an antioxidant and an antineoplastic agent. It is a secondary alpha-hydroxy ketone and a dihydromyricetin. It is an enantiomer of a (-)-dihydromyricetin. Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus). Dihydromyricetin is a naturally occurring flavonoid found in the many plant species and is thought to be the active ingredient of several traditional Japanese, Chinese, and Korean medicines that are used to treat fever, parasite infections, liver diseases, and hangovers. Dihydromyricetin preparations have not been linked to instances of serum enzyme elevations or clinically apparent liver injury with jaundice. Dihydromyricetin is a natural product found in Vitis rotundifolia, Catha edulis, and other organisms with data available. (±)-trans-3,3,4,5,5,7-Hexahydroxyflavanone is found in tea. (±)-trans-3,3,4,5,5,7-Hexahydroxyflavanone is a constituent of Camellia sinensis (Chinese green tea). Constituent of Camellia sinensis (Chinese green tea). (±)-Dihydromyricetin is found in tea. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
2,3-Dihydrogossypetin
A member of the class of dihydroflavonols that is the 2,3-dihydro derivative of gossypetin.
7-(Benzyloxy)-4-(trifluoromethyl)-2H-chromen-2-one
(2S)-4,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-one
2-[1-(2-Fluorophenyl)ethylamino]-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4-one
Ethyl brevifolincarboxylate
Ethyl brevifolincarboxylate, also known as ebfc, belongs to isocoumarins and derivatives class of compounds. Those are polycyclic compounds containing an isochromane which bears a ketone at the carbon C1. Ethyl brevifolincarboxylate is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Ethyl brevifolincarboxylate can be found in pomegranate, which makes ethyl brevifolincarboxylate a potential biomarker for the consumption of this food product.
ampelopsin
Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
1-(3-methoxyphenyl)-3-(methyl-oxo-phenyl-$l^{6}-sulfanylidene)thiourea
C15H16N2O2S2 (320.06531559999996)
2,5,7-Trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-on|2,5,7-trihydroxy-2-(3,4,5-trihydroxy-phenyl)-chroman-3-one
(1S)-1,5,8,10-tetrahydroxy-7-methoxy-3-methyl-6,9-dihydro-1H-naphtho[2,3-c]pyran-6,9-dione|coronatoquinone
(Z)-4-hydroxy-3-(7-hydroxy-4-chromoyl)-hex-2-enedioic acid
Dihydromyricetin
A hexahydroxyflavanone that is the 2,3-dihydro derivative of myricetin. Dihydromyricetin, also known as ampelopsin or (2r,3r)-3,5,7,3,4,5-hexahydroxyflavanone, is a member of the class of compounds known as epigallocatechins. Epigallocatechins are compounds containing epigallocatechin or a derivative. Epigallocatechin is a flavan-3-ol containing a benzopyran-3,5,7-triol linked to a 3,4,5-hydroxyphenyl moiety. Dihydromyricetin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Dihydromyricetin can be found in a number of food items such as highbush blueberry, summer grape, sacred lotus, and sweet rowanberry, which makes dihydromyricetin a potential biomarker for the consumption of these food products. Hovenia dulcis has been used in traditional Japanese, Chinese, and Korean medicines to treat fever, parasitic infection, as a laxative, and a treatment of liver diseases, and as a hangover treatment. Methods have been developed to extract ampelopsin from it at large scales, and laboratory research has been conducted with the compound to see if it might be useful as a drug in any of the conditions for which the parent plant has been traditionally used . Isolated from flowers of Eugenia jambolana (jambolan). trans-3,3,4,5,5,7-Hexahydroxyflavanone is found in fruits. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
[4-[3,5-bis(trifluoromethyl)phenyl]phenyl]methanol
N-[6-[(2-chloro-4-hydroxyphenyl)imino]-4-methoxy-3-oxo-1,4-cyclohexadien-1-yl]acetamide
C15H13ClN2O4 (320.05638080000006)
(1S, 2S)-1,2-Bis(4-fluorophenyl)ethylenediamine dihydrochloride
((7-Oxo-7H-benz(de)anthracen-3-yl)thio)acetic acid
(4-((TERT-BUTYLDIMETHYLSILYL)OXY)-3,5-DICHLOROPHENYL)BORONIC ACID
C12H19BCl2O3Si (320.05735139999996)
4-(4-(4-(trifluoromethyl)phenyl)thiazol-2-yl)benzenamine
Ethyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate
C15H13ClN2O4 (320.05638080000006)
Ethyl [(4-chloro-3-cyano-6-methoxy-7-quinolinyl)oxy]acetate
C15H13ClN2O4 (320.05638080000006)
1-bromo-2-fluoro-4-(4-pentylphenyl)benzene
C17H18BrF (320.05758199999997)
N-(2-Formyl-4-nitro-phenyl)-4-methyl-benzenesulfonamide
1-[4-(6-METHYL-BENZOTHIAZOL-2-YL)-PHENYL]-PYRROLE-2,5-DIONE
Methyl (E)-2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate
C15H13ClN2O4 (320.05638080000006)
chloropalladium(1+),(1Z,5Z)-cycloocta-1,5-diene,2-methanidyl-2-methylpropane
2-(CHLOROMETHYL)-3-(4-CHLOROPHENYL)-2-METHYL-1,2,3,4-TETRAHYDROQUINAZOLIN-4-ONE
2-butoxyethyl 2,4-dichlorophenoxyacetate
C14H18Cl2O4 (320.05820880000005)
5-(2-CHLORO-1,1-DIMETHYLETHYL)-3-[4-(TRIFLUOROMETHOXY)PHENYL]-1,2,4-OXADIAZOLE
(5s)-2-{[(1s)-1-(2-Fluorophenyl)ethyl]amino}-5-Methyl-5-(Trifluoromethyl)-1,3-Thiazol-4(5h)-One
3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-4-one
7-(Benzyloxy)-4-(trifluoromethyl)-2H-chromen-2-one
N-(4-fluorophenyl)-2-oxo-3,4-dihydro-1H-quinoline-6-sulfonamide
[3-Methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone
C15H16N2O2S2 (320.06531559999996)
2-[(6-chloro-1-benzotriazolyl)oxy]-N-(4-fluorophenyl)acetamide
C14H10ClFN4O2 (320.04762819999996)
5-(4-Methylphenyl)-2-methylsulfonyl-3-thiophen-2-yl-3,4-dihydropyrazole
C15H16N2O2S2 (320.06531559999996)
2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxy-2,3-dihydrochromen-4-one
7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-1H,10H-pyrano[4,3-b]chromene-9-carboxylic acid
An organic heterotricyclic compound that is 1H,10H-pyrano[4,3-b]chromene substituted by hydroxy groups at positions 7 and 8, a methoxy group at position 1, a methyl group at position 3 and an oxo group at position 10. Isolated from Chaetomium funicola, it exhibits inhibitory activity against metallo-beta-lactamases.
Octulose 8-phosphate
A ketooctose derivative that is D-glycero-D-altro-octulose carrying a single phosphate substituent at position 8.
[(2R,3R,4S,5S)-3,4,5-trihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl] dihydrogen phosphate
[(2R,3R,4R,5R,6S,7R)-2,3,4,5,6,7-hexahydroxy-8-oxooctyl] dihydrogen phosphate
[(2R,3S,4R,5R)-3,4-dihydroxy-5-(4-methylphenoxy)oxolan-2-yl]methyl dihydrogen phosphate
C12H17O8P (320.06610120000005)
[(2R,3R)-2,3-dihydroxy-3-[(3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]propyl] dihydrogen phosphate
5-Nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester
1-[(2,4-dichlorophenyl)methyl]-3-[(E)-2-phenylethenyl]urea
3-(3,4-Dihydroxyphenyl)-1-(2,3,4,5,6-pentahydroxyphenyl)prop-2-en-1-one
[(3S,4R,5R,6R,7R)-3,4,5,6,7,8-hexahydroxy-2-oxooctyl] dihydrogen phosphate
Phenyl-3-trimethylstannylpropyl sulfide
C12H24SSn (320.06206139999995)
Ampelopsin
(+)-dihydromyricetin is an optically active form of dihydromyricetin having (2R,3R)-configuration. It has a role as a metabolite, an antioxidant and an antineoplastic agent. It is a secondary alpha-hydroxy ketone and a dihydromyricetin. It is an enantiomer of a (-)-dihydromyricetin. Dihydromyricetin is under investigation in clinical trial NCT03606694 (Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus). Dihydromyricetin is a naturally occurring flavonoid found in the many plant species and is thought to be the active ingredient of several traditional Japanese, Chinese, and Korean medicines that are used to treat fever, parasite infections, liver diseases, and hangovers. Dihydromyricetin preparations have not been linked to instances of serum enzyme elevations or clinically apparent liver injury with jaundice. Dihydromyricetin is a natural product found in Vitis rotundifolia, Catha edulis, and other organisms with data available. An optically active form of dihydromyricetin having (2R,3R)-configuration. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM. Dihydromyricetin is a potent inhibitor with an IC50 of 48 μM on dihydropyrimidinase. Dihydromyricetin can activate autophagy through inhibiting mTOR signaling. Dihydromyricetin suppresses the formation of mTOR complexes (mTORC1/2). Dihydromyricetin is also a potent influenza RNA-dependent RNA polymerase inhibitor with an IC50 of 22 μM.
(2E,4E)-2,4-Dihydroxy-4-[6-(4-hydroxyphenyl)-2,4-dioxodihydro-2H-pyran-3(4H)-ylidene]but-2-enoate
4-hydroxy-3-(7-hydroxy-4-oxochromen-3-yl)hex-2-enedioic acid
(3s)-4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione
4,5,10-trihydroxy-7-methoxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione
1,4-dihydroxy-6-methoxy-5,8-dioxo-3-(2-oxopropyl)naphthalene-2-carboxylic acid
2-o-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-phenylaceticacid
{"Ingredient_id": "HBIN006164","Ingredient_name": "2-o-(3,4-dihydroxybenzoyl)-2,4,6-trihydroxy-phenylaceticacid","Alias": "NA","Ingredient_formula": "C15H12O8","Ingredient_Smile": "C1=CC(=C(C=C1C(=O)OC2=CC(=CC(=C2CC(=O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5767","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,5,7,2',6'-pentahydroxy flavonol
{"Ingredient_id": "HBIN007566","Ingredient_name": "3,5,7,2',6'-pentahydroxy flavonol","Alias": "NA","Ingredient_formula": "C15H12O8","Ingredient_Smile": "C1=CC(=C(C(=C1)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)(O)O)O","Ingredient_weight": "320.25 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT19413","TCMID_id": "31765","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129892149","DrugBank_id": "NA"}